Maximus Alternatives: What Changes in Your Treatment, Your Bill, and Your Commitment

Maximus alternatives depend on what you need to change: Male Excel advertises no contract, while Taurus Meds and Hone list enclomiphene. Maximus itself lists $99.99 monthly on both six- and twelve-month enclomiphene terms. Compare your remaining commitment before switching. Unconfirmed low testosterone or near-term fertility plans call for clinical evaluation, not a price-led choice. ^{1, 7, 24, 26, 17, 32}

By TRT Provider Guide

Published 2026-09-11 · Last updated 2026-09-11 · Last verified September 2026

Editorial research, not clinically reviewed.

---

Educational information, not medical advice. Testosterone is a Schedule III controlled substance and requires a prescription and clinical supervision. If you have chest pain, severe shortness of breath, or another urgent symptom, seek emergency care. ^{20, 17}

Best for you if / Not for you if

This is for you if you're on a Maximus plan and want out, or you're looking at Maximus's checkout page and the commitment length is making you hesitate.

This is probably not for you if you want a diagnosis from a price table, a guaranteed prescription, or permission to change your own treatment. If your low testosterone has never been confirmed, if you're trying to conceive soon, or if you have a complicated medical history, the sections near the bottom of this page point you somewhere better. This comparison covers Maximus's hormone-care options for adult men evaluating testosterone deficiency, not care for women, adolescents, gender-affirming treatment, or nonmedical performance use.

---

Here's the number worth checking before you leave: Maximus publishes the exact same base monthly rate on a 6-month plan as on a 12-month plan. On all eighteen of the price table's protocols. Before any promotion, the longer term doesn't get you a lower monthly rate. It doubles the term you commit to. ¹

That's published openly in Maximus's own help center. We'll show you the table. ¹

---

Which Maximus alternatives fit your reason for leaving?

The right alternative depends on which part of Maximus you're trying to replace — the commitment, the medication, the care model, or the whole online approach. A cheaper monthly price does not answer all four. Match the reason first, then compare the bill.

Here are five reasons to compare. Find yours.

^{1, 4, 7, 8, 24, 26, 11}

Affiliate disclosure: Male Excel and Taurus Meds are commercial partners of TRT Provider Guide. This page uses direct links to public information, not tracked referral or enrollment links. Hone Health, Defy Medical, Marek Health, Maximus, and the local-care route are here because the evidence puts them here — we earn nothing from any of them. Read our affiliate disclosure.

TRT Provider Guide is the independent decision resource for testosterone replacement therapy — helping U.S. adults understand how low testosterone is evaluated, compare online and local care models and providers, and choose the next step that fits their health needs, fertility plans, budget, state, and care preferences, with every material claim verified and dated.

How we label things on this page

We use five labels and we don't blur them:

• 🔵 Verified fact — checked against the official record, guideline, label, or research paper.
• 📄 Provider-stated — the company says this. We're repeating it with attribution; reading a policy is not testing the service.
• 🧮 Our calculation — arithmetic we did from published numbers. A subtotal is not a personal quote.
• 💬 Customer-experience signal — an attributable customer report. It cannot establish a policy, a medical outcome, or a typical experience by itself.
• Our editorial conclusion — a judgment about a documented offer, not a medical score.

Why the right provider isn't the same for every man

The right TRT provider is not the same for every person — it depends on whether low testosterone has been properly evaluated, your symptoms and health history, your fertility plans, your state, your insurance or cash-pay preference, your treatment-format preference, your budget, and whether online or in-person care is the better starting point. Some situations belong with primary care, urology, endocrinology, reproductive urology, or urgent or emergency care when the symptoms warrant it. Because a general answer cannot resolve those for you, use TRT Provider Guide's Find My TRT Path tool to map your situation to the right care route and the questions to ask before you pay.

That tool won't pick your medication or tell you whether you qualify. Those decisions belong to a clinician, not a comparison tool.

---

Before you leave, which three Maximus terms should you check?

Maximus publishes a full price matrix, a one-time purchase option, and a medical exit clause in its terms. They give you three things to check before paying a replacement provider, though the medical exit must be confirmed for your agreement.

None of this earns us anything, and it's the most useful part of this page. ^{1, 3, 4}

Let's take them in order: the next commitment, a non-renewing order, and an exception to ask about.

1. The 6-month plan has the same monthly rate as the 12-month plan

📄 This is from Maximus's own help center page, Enclomiphene Subscription Plans & Pricing, which lists eighteen protocols across four subscription lengths and a one-time option. We checked it on September 11, 2026. ¹

Here's a slice of it:

¹

These are the provider's plan labels and base prices, not interchangeable prescriptions. The one-time column does not establish an equal supply length or an all-in care price.

Look at the two bolded columns. They're the same number. And they're the same number on every one of the eighteen rows, not just these six. ¹

🧮 So on the enclomiphene plan, a 6-month term is a $599.94 commitment and a 12-month term is a $1,199.88 commitment — at an identical $99.99 a month. ¹

📄 Maximus also advertises 50% off the first month for new clients on a 12-month plan. On a $99.99 plan that's worth about $50, subject to the actual offer at payment. It does not make the base six- and twelve-month rates different. ²

Our editorial conclusion: doubling a commitment from roughly $600 to roughly $1,200 in exchange for a one-time ~$50 discount is a bad trade for someone whose main concern is being locked in. For a new eligible term, the 6-month plan gets you the same published base monthly price with half the commitment. It does not shorten a term you already accepted or guarantee the price of a later renewal.

We're not accusing anyone of hiding this. The table is public and anyone can open it. But you need both the monthly rate and the total term beside each other to see the tradeoff.

2. There's a one-time purchase option

📄 That same table has a column labelled OTP — one-time purchase. Enclomiphene is listed at $99.99, injectable TRT at $99.99, topical TRT at $109.99. ¹

That's a way to place an eligible order without starting a subscription at all. If your problem is "I don't want to be locked into anything," ask whether this option is available for your prescribed treatment. ³

Confirm what an OTP order actually includes before you use it — how many days of medication, whether labs and clinician review are covered, and what happens when you need a refill. A one-time purchase is not an ongoing care plan, and testosterone requires ongoing monitoring. ^{1, 3, 17}

3. The terms describe a medical exit — confirm it for your agreement

📄 Maximus's Terms of Use, last updated February 25, 2026, describe what happens when you cancel a Subscription Savings Plan mid-term. The general rule is what you'd expect: you stay responsible for the remaining monthly payments through the end of the term. ³

But the same section adds an exception. Participants who are unable to continue the program due to health-related issues, as determined by a healthcare provider, may cancel the commitment without further charges. Documentation may be required, and medication already shipped is not refunded. ³

The documents do not line up neatly. The later Return, Refund & Subscription Policy, effective April 15, 2026, says committed terms cannot be ended early and allows case-by-case exceptions; it does not repeat that medical clause. Get written confirmation of which provision applies to your account before treating the balance as cancelled. ⁴

📄 Two practical details that matter more than the clause itself:

• Turning off auto-renewal is self-service in your dashboard. Cancelling a committed term is not. Maximus's terms route those requests to its support email.
• Maximus's Return, Refund & Subscription Policy, effective April 15, 2026, says billing disputes should be raised in writing, and that disputing a charge with your bank before contacting support may put your account on hold. ^{3, 4}

If a clinician has told you the program cannot continue for a health reason, ask support to apply the medical-exit clause and confirm the remaining balance. Put the request in writing and keep a copy. A provider's billing-dispute policy is not a statement of all your consumer rights.

Credit where it's due

We spend a lot of this page on Maximus's commitment structure, so it's only fair to name what it does well. 📄 Its published policy makes auto-renewal self-service, with no phone call required, and promises 30 days' written notice before material changes to pricing, cadence, cancellation rights, or refund terms. Its site-wide disclosure also says compounded medications are not FDA-approved and that its published results come from its own open-label observational studies. Those are useful disclosures. ^{4, 2}

Those are real. They're just not the same thing as a short commitment. ^{4, 2}

---

What does your Maximus plan actually cost?

The $99.99 monthly headline applies to a committed plan, not the month-to-month option. Labs sit outside the protocol price, and a few charges appear in the terms. Start from your total committed amount, then add testing, before you compare anything else. ^{1, 3, 23}

The full ladder, from Maximus's own pages

📄 For the enclomiphene protocol, the published tiers are:

^{1, 3, 4}

Promotions and labs are excluded. The help-center table gives full-term totals; the subscription policy says committed plans may be prepaid or billed in installments. Check the amount actually due now, not just the monthly equivalent.

🧮 Over twelve months, that's $2,399.88 at the month-to-month rate versus $1,199.88 for the annual term: a $1,200 difference before labs and promotions, assuming unchanged prices. It's the clearest illustration on this page of what a commitment actually buys. ¹

What the protocol price does not include

📄 Maximus's Subscription Savings Plan terms state that the Testosterone Protocol includes telemedicine visits during the term, prescription medication, and shipping — and that it does not include video consultations where applicable, or at-home or in-person blood tests, which are required for treatment. ³

📄 Maximus's own enclomiphene page confirms lab testing is required and says any lab fee is disclosed in writing before your card is charged. That's the right way to handle it. But it means the headline price is not your bill. ⁶

📄 Two smaller charges appear in the terms: a possible $20 no-show fee for a missed live video consultation, and a possible $20 fee for rescheduling inside 24 hours. ³

📄 Maximus's lab policy lists a $99 home kit, Quest panels from $19.99 to $115, and testing at baseline, one month, three months, and twelve months, with other tests as clinically needed. Follow-up tests are separate charges. Qualifying outside results from the last six months may be uploaded without a lab fee. ²³

The lab bill is not settled by counting kits. The same policy describes a full protocol panel in one place and only total and free testosterone for the home option in another. Ask for the exact markers, repeat diagnostic test, follow-up dates, and price of each required panel. We cannot turn that conflict into a complete first-year lab total. ²³

Will your monthly price change mid-term?

This one needs care, because Maximus's own pages point two ways and we're not going to pick the friendlier answer.

📄 The Subscription Savings Plan terms say committed plans are billed monthly with charges "not falling below the agreed-upon minimum rate," and that changes in treatment care during the commitment term may result in higher or lower monthly charges depending on the prescribed plan. ³

📄 But Maximus's enclomiphene product page says treatment "includes any dosage of the medication, doctor consultation, and shipping," with no membership fees. ⁴¹

One possible explanation is that a dose change within enclomiphene is included while a protocol change (say, adding testosterone cream) moves you to a different, more expensive row. We have not confirmed that explanation for an individual agreement. The matrix shows why it matters: Enclomiphene is $99.99 on a 6-month term, while Enclomiphene + Topical TRT is $149.98. ^{1, 3, 41}

Ask which applies to your plan, in writing, before you commit. The question is: "If my prescription changes during the term, what changes about my monthly charge?"

---

Are you changing providers — or changing treatments?

Maximus lists enclomiphene and injectable, topical, and oral testosterone; enclomiphene is not testosterone replacement therapy. Switching companies creates a new care relationship as well as a billing decision. Switching medications is a clinical decision, and only a prescriber who knows your history can make it. ^{2, 21}

The names can make unlike offers look alike, so let's be precise.

🔵 Enclomiphene is a selective estrogen receptor modulator (SERM) — a drug that blocks estrogen signalling at the brain, which can raise the pituitary hormones LH (luteinizing hormone, which tells the testicles to make testosterone) and FSH (follicle-stimulating hormone, which supports sperm production). Your own testicles do the work. ³⁴

🔵 Testosterone — injectable, cream, or oral — replaces the hormone from outside. That can suppress your own production. ³²

They are different drugs with different mechanisms and different regulatory status. Enclomiphene is not FDA-approved for any condition; the enclomiphene offers discussed here are compounded preparations. Compounded drugs are not FDA-approved and are not approved generic versions of anything. ^{19, 21}

Clomiphene is different again. Clomid has an FDA-approved indication for certain ovulation problems in women; its use for male testosterone deficiency or infertility is off-label. That does not make a compounded clomiphene combination FDA-approved. hCG is a separate hormone, not testosterone; an hCG-containing plan is not a guarantee of fertility. ^{33, 32}

Keep FDA-approved testosterone products separate from compounded testosterone too. An ingredient name or the word “oral” does not identify the approved product. Maximus describes its oral testosterone as custom-compounded, not an approved generic version of a branded oral testosterone drug. ^{19, 42}

hCG has product-specific labeled uses. Pregnyl's U.S. prescribing information includes selected cases of hypogonadotropic hypogonadism in males — low hormone production due to inadequate pituitary signaling. That is not a general approval claim for adding hCG to any TRT plan to preserve fertility. Ask which exact product and indication the clinician means. ^{43, 32}

So work out which switch you're actually making:

📄 Worth knowing: Maximus's help center says switching between formulations inside Maximus also requires clinician approval, and plan changes take effect at your next refill. So even an internal switch is a clinical conversation, not a dropdown. ⁵

For a wider enclomiphene-only shortlist, use our dedicated comparison. We compared seven enclomiphene offers — ingredients, lab requirements, commitments, and what can actually be calculated from the published cash-pay prices. This page's job is the Maximus switch: what changes in your treatment, your bill, and your commitment.

Compare enclomiphene providers by what's actually in the capsule →

---

What will switching actually cost you?

Leaving a committed plan does not cancel the money you still owe on it. Your real switching cost is the unavoidable remainder of the old plan plus the new provider's charges over the same time window, minus any refund you've confirmed in writing. Money you already paid and can't recover is a sunk cost, not a future bill. ^{3, 4}

Here's the arithmetic, because getting this wrong is how men talk themselves into paying twice.

Future cash you'll need = unavoidable remaining payments on your current plan + the new provider's costs over the same period − refunds you've confirmed in writing

The trap is double-counting. If you already paid $300 that you can't get back, that money is gone whether you switch or not. Don't add it to the cost of switching. It belongs in a separate line — "already spent" — because it is not another future charge. Show any overlapping paid care separately, and compare the cost of staying over the same future period.

🧮 A worked example, clearly hypothetical:

• You're 4 months into a 12-month enclomiphene plan at $99.99/month.
• Remaining obligation: 8 × $99.99 = $799.92, assuming no approved release, refund, or other adjustment.
• A new provider's first year: call it $1,200.
• Future cash over the next 12 months: $1,999.92 — about $2,000.
• Already paid: $399.96. Real, but not another future payment.

That's the number that should drive your choice — not the headline monthly rate of whoever you're looking at.

Your switch-cost worksheet

Copy this into your own notes. Use one start date and one end date for both options; an unanswered cost stays unknown, not zero.

Message to Maximus: Please confirm my term end date, renewal status, remaining payments and shipments, and any approved cancellation or refund. Please explain how I can obtain my complete clinical records.

Message to the alternative: Please give me an itemized quote with the exact treatment, testing requirements, charge dates, cancellation deadline, and all required fees. Please identify the treating clinician and dispensing pharmacy and explain the clinical handoff.

Put your quoted charges into the TRT cost worksheet →

The expensive part we won't hide

Switching to Male Excel is not a cost-saving move against Maximus's published six- or twelve-month injectable starting rate. Its no-contract offer costs substantially more before unresolved testing and shipping charges.

🧮 Male Excel's published structure produces a $2,727 annualised subtotal for its starting injectable example — a $99 consultation, $99 a month for required membership, and medication from $120 a month. Against Maximus's 12-month injectable base plan at $1,199.88, that's more than double. This compares payment structures, not equivalent prescriptions: Male Excel's example also includes thyroid medication, and the complete testing bill is not settled. ^{7, 1}

If the lowest possible annual number is what matters most to you, compare Maximus's shorter eligible term with an itemized quote from your own clinician and insurer before paying another clinic. Neither is a guaranteed cheapest route, but both deserve a place in the comparison. Skip to those sections. We mean it.

A low annual price and a short billing commitment are different priorities. Maximus's refund policy encourages new patients to start month-to-month before making a longer commitment. Male Excel prints “No Contract, Cancel Anytime” on its pricing page. You're not buying a discount. You're considering flexibility over future billing — not permission to stop medication without clinical guidance, and not a refund for past charges. ^{4, 7, 9}

---

Does Male Excel solve the contract problem, and what does it cost?

📄 Male Excel advertises “No Contract, Cancel Anytime” and describes medication in 60-day supplies billed every other month. Its structure stacks three charges: a $99 one-time consultation, a required $99-a-month medical membership, and dose-dependent medication. 🧮 For its starting injectable example, that gives a $2,727 annualised subtotal, not a complete first-year cash quote. ⁷

Let's take the cost apart, since that's the part that surprises people.

What you actually pay

📄 Verified against Male Excel's published pricing page on September 11, 2026:

⁷

📄 Every tier is marked FSA/HSA eligible and “No Contract, Cancel Anytime.” Medication is shown as billed every other month, separate from the monthly membership. The terms also say sales and fees are generally final and nonrefundable. No contract does not mean money back for medicine or services already paid for. ^{7, 9}

🧮 Our annualised subtotals: $2,727 for injectable ($99 + 12 × $99 + 12 × $120), $2,871 for the cream, and $2,427 for Triclozene at the $95 example. At the competing $120 oral figure, the oral subtotal would be $2,727. These exclude shipping and handling, separately charged tests or services, dose changes, and any extra refill charge inside the selected dates. ⁷

Annualised is not the same as cash paid in twelve months. Six 60-day supplies cover 360 days. If actual billing runs every 60 days starting on day zero, a seventh charge can fall on day 360; billing every other calendar month gives a different schedule. Ask for the dated payment calendar rather than assuming these subtotals are all-in annual bills.

📄 Note the pricing page's own footnote: prices shown are for a typical starting dosage and may vary with your biochemistry and what your provider prescribes. Get your specific number at checkout. ⁷

What the membership buys

📄 Male Excel says the $99 monthly membership includes a dedicated provider, unlimited messaging with the support team, and unlimited e-visits with your medical provider. Its oral-product page describes a $99 at-home test and consultation entry offer. Those statements do not settle whether a second diagnostic test and all later monitoring panels are included in your selected plan. ^{7, 8}

Our editorial conclusion: access to additional e-visits can matter to someone arranging a handoff. But “unlimited” is not a verified response time, round-the-clock clinician availability, or better medical outcomes. Whether that's worth $1,188 a year is your call, but it isn't nothing. Ask who answers, how quickly, and which tests or visits cost extra.

Two things we won't repeat, and one you need to know

📄 Male Excel markets its testosterone as "bioidentical" and describes its cream as "20x more powerful than commercial cream." Those are the company's words. We're not adopting either. Compounded preparations are not FDA-approved, and "bioidentical" is a marketing term, not a safety or quality standard. ^{7, 19}

More important, and this is the reason Male Excel is not our recommendation for everyone leaving Maximus:

We cannot verify Triclozene as a plain-enclomiphene substitute. 📄 Its pricing page describes clomiphene citrate with thyroid and selenomethionine; its product page describes enclomiphene with added ingredients. 🔵 Clomiphene contains two isomers — enclomiphene and zuclomiphene — so the names are not interchangeable. The Clomid label describes zuclomiphene as more estrogenic and longer-lasting than enclomiphene; that does not establish which ingredient is in today's Triclozene order. ^{7, 8, 33}

📄 Male Excel's own pages don't agree on this. Its Triclozene product page is headlined around enclomiphene; its pricing page names clomiphene. We're not going to invent an explanation for the discrepancy. We covered it in detail, with both pages cited, on our enclomiphene provider comparison. ^{7, 8}

Male Excel is a paid partner of ours, and it is not a verified answer to “where else can I get plain enclomiphene?” We'd rather say that than sell you something you didn't ask for.

Who should choose something else

• You want the lowest annual bill. Compare Maximus's eligible shorter term and the local-care route before assuming a switch saves money.
• You want plain enclomiphene. See the enclomiphene comparison above.
• You want hCG alongside testosterone or have fertility concerns. Start with a fertility-aware clinician; a broader menu is not proof that a combination is right for you.
• You want insurance to pay. 📄 Male Excel's terms describe a cash-pay service, do not accept insurance, and say users agree not to seek reimbursement from government or commercial payers for its services. See the local-care section. ^{9, 32}

What we could not confirm

The live pricing page itself gives two oral prices, and its oral-product descriptions do not agree. We also did not establish treatment-specific availability, an assigned clinician's state authority, or the pharmacy that would fill an individual order. An online form is not confirmation of any of those things. ^{7, 8}

The thyroid medication in the examples is another treatment, not a free bonus. Ask why it is needed, what its own approval status is, and what the quote would contain if it is not prescribed. Do not assume a testosterone ingredient name identifies an FDA-approved finished product. ^{7, 19}

If no multi-month commitment and access to additional e-visits are what you're comparing:

See Male Excel's published pricing, membership, and exclusions →

Confirm your prescription-specific total, required tests, shipping, cancellation timing, and the treating clinician's authority in your state before you pay. Male Excel says an in-person exam may be required. No intake form guarantees a prescription. ^{7, 38}

---

Does Taurus Meds offer the treatment and shorter term you need?

📄 Taurus Meds lists enclomiphene at $149 a month and a $49 start with blood testing through LabCorp or Quest and clinical review. Its terms make cancellation effective at the end of the current paid period. The public product page does not establish a six-month-versus-month-to-month price grid, so get the selected term in writing. ^{24, 10}

For someone keeping enclomiphene on the shortlist, Taurus has a relevant published offer. Whether it solves the commitment problem depends on the actual paid term and fees — not the monthly headline.

What its own terms say

📄 Verified against Taurus's published terms:

• Subscriptions auto-renew unless cancelled. Cancellation takes effect at the end of the current paid term.
• All sales on shipped medications are final. No refunds.
• No refunds on blood work, because the order goes to the lab partner immediately on payment.
• Prices may change at any time. ¹⁰

📄 Taurus names Red Rock Pharmacy, HealthWarehouse, Precision Compounding Pharmacy, and Triad Rx in its terms. It identifies OpenLoop as a partner management services organization, not as the name of your assigned treating clinician. Pharmacy disclosure is a real credit and worth asking about at any provider; these names do not verify which pharmacy fills your order or its authority in your state. ¹⁰

A shorter advertised price is not a shorter contract

Be honest with yourself here. If the commitment is what you're escaping, a lower monthly equivalent is not enough. Ask whether the $149 offer renews monthly, requires prepayment, or creates a longer obligation; the public page alone does not settle it. ^{24, 10}

We'd rather you paid a clear price knowingly than picked a headline and ended up back on this page in March.

The fee we could not resolve

📄 Taurus's general terms specify $17.99 per billing period for a recurring membership unless otherwise stated at purchase. We could not confirm whether it applies to this hormone-care offer, is included, or how often that billing period occurs. 🧮 The base arithmetic of $49 plus 12 × $149 is $1,837, not an established all-inclusive annual price. ^{10, 24}

If that extra fee applied once a month, it would add $215.88 a year, making that same subtotal $2,052.88. That's a fee-sensitivity calculation, not a verified quote or a claim that the fee is monthly.

One approval claim needs a direct correction. Taurus's enclomiphene page includes wording about FDA-approved medications and a rapid “FDA-certified TRT” approval. Enclomiphene is not an FDA-approved drug, and a payment or questionnaire does not guarantee a prescription. Do not treat that page language as approval of the compounded product you would receive. ^{24, 21, 19}

Before you pay Taurus, get these three answers in writing: Does any recurring platform fee apply on top of the protocol price, and how often is it billed? Is the specific product I'll receive FDA-approved or compounded? Which pharmacy dispenses it, and is it licensed for my state? ^{10, 24}

📄 Taurus's separate refund policy requests cancellation at least 72 hours before the next billing cycle; its terms say cancellation takes effect at the end of the paid period. The refund page also contains weight-loss-specific language, so confirm its application to your hormone-care purchase. Save the accepted terms and written cancellation confirmation before a dispute, not after. ^{25, 10}

Who should choose something else

• You need a settled total before you hand over a card. Resolve the fee question first, or look elsewhere.
• You need an FDA-approved finished product. A compounded enclomiphene offer does not meet that requirement. Discuss a different, clinically appropriate treatment with your clinician.
• You want a published breakdown of where your money goes. Hone has an older fee-allocation document, but its current rate also needs a fresh quote.

If keeping enclomiphene is your reason to compare, start with the offer — not an assumption that the term is shorter:

Read Taurus Meds' enclomiphene offer and compare the fee questions →

Ask specifically about the paid term, the $17.99 clause, required repeat tests, and the prescribing clinician and pharmacy for your state. Get the answers in writing.

---

Which alternatives belong here even though they don't pay us?

Hone belongs here for its published membership and testing details, including a fee-allocation document worth comparing with its newer price. Defy Medical and Marek also have public care offerings, but we did not establish complete current treatment quotes for them. None of these is a paid placement on this page. ^{26, 11, 39, 40}

Hone Health

📄 Hone's current Plus page lists $135 a month for membership — $1,620 over twelve months — before medication and initial testing. Its current FAQ says cancellation takes effect at the end of the billing period. The $129 monthly figure in its older payment document is not the current Plus offer. ^{26, 12, 11}

📄 Hone also publishes a useful older breakdown. Its May 28, 2026 payment document allocates the former $1,548 annual membership as follows; this is not an allocation of today's $1,620 rate: ¹¹

¹¹

The older document also describes a refund of an initial $129 membership payment when treatment is ruled out. Do not assume that establishes a refund of the current $135 fee; ask for the rule attached to your purchase. 📄 For TRT, Hone's current process explicitly calls for a second total-testosterone measurement and other confirmatory markers. The new clinician still decides what testing is needed. ^{11, 26}

📄 For an enclomiphene comparison, the current published starting figures are $45 for the initial test, $135/month membership, and medication starting at $42/month. 🧮 That gives $2,169 over twelve months at unchanged prices, before any extra initial or diagnostic testing and any difference in your prescription price. Follow-up labs, consultations, and shipping are listed as included. ²⁶

Two details keep this from being a universal all-in quote. The Plus page lists a TRT confirmatory draw at $45 in a lab or $80 at home; the separate TRT schedule lists $50 for the in-lab option. And the testosterone injection price is $28 per vial, not per month. Ask for the final test charge and the number and timing of vials before calculating an injectable annual bill. ^{26, 27}

Our editorial conclusion: that fee breakdown should be the category standard. It lets you see clinical, laboratory, and platform charges separately. But transparency also means keeping the split aligned with the current price; we cannot assign today's extra $72 a year to any category without an updated document.

📄 Hone's detailed first-year schedules list TRT follow-up testing at months 3, 6, 9, and 12, and non-TRT follow-up at 3, 6, and 12, with changes based on the clinical plan. The non-TRT page also uses broader quarterly wording, so confirm the dates in your own plan rather than treating the introduction as a fixed promise. ^{27, 28}

See Hone's current membership, medication estimates, and testing charges →

Defy Medical and Marek Health

📄 Defy Medical's current site describes hormone-care services, testing, and consultations. Marek's active diagnostics site links to its Guided Optimization care program. A laboratory storefront is not a complete treatment price, and neither name establishes that a clinician will accept your case or prescribe a particular medicine. ^{39, 40}

We did not verify a complete, current care quote for either provider. We're not going to launder unverified estimates into this page. Ask for an itemized quote covering evaluation, repeat tests, follow-up, medication, pharmacy charges, and any recurring service fee. A complicated history or fertility concern is a reason to seek the right clinician, not assume that a broader advertised menu is better care. ^{17, 32}

Why we're telling you about companies that don't pay us

Because a list containing only our partners isn't a list. It's an ad, and you'd be able to tell.

---

Could a local clinician and insurance cost less?

An in-network clinician and a covered FDA-approved testosterone product can cost less than a cash-pay subscription. That is an option to price, not a guaranteed cheapest route: your deductible, copays, testing, and drug coverage decide the bill. Insurance coverage and clinical eligibility are separate decisions. ³⁵

Here's how it works: your primary care clinician or a specialist evaluates you, orders appropriate morning blood tests, and considers treatment only when the findings and your health history support it. Ask the insurer to check the visits, laboratory work, and exact prescription separately. A pharmacy quote alone is not the full cost of care. ^{17, 29, 35}

A normal result during successful treatment does not automatically end insurance coverage. For example, Aetna's testosterone-cypionate policy includes continuation criteria tied to qualifying pretreatment testosterone results and other conditions. Male Excel's broader explanation that coverage can stop when a level becomes normal is not a rule you can apply to every insurer or plan. ^{35, 7}

What this route may cost you instead: appointment waits, referrals when required, and coordinating the prescriber, lab, pharmacy, and insurer. Ask about those steps before deciding. There is no reason to assume every local practice provides less support or every online service is faster.

One thing to check regardless: an FSA or HSA may pay qualifying medical expenses, but a provider's eligibility badge is not approval of every subscription charge. Ask your plan administrator about the exact medication, visits, labs, and platform fees, and keep itemized receipts. Expenses cannot be counted again if already reimbursed. ³⁶

For the wider decision, see our comparison of online and local TRT care.

---

What do the current telemedicine rules mean for your commitment?

The current federal extension permits qualifying controlled-medication prescribing without a prior in-person exam through December 31, 2026, subject to its conditions. That does not mean every online testosterone prescription depends on this exception, or that online care becomes illegal the next day. Ask how your provider would handle any change that affects your care or agreement. ^{13, 14}

Here's what the rule does — and what it doesn't.

🔵 Testosterone is a Schedule III controlled substance. The Ryan Haight framework generally requires a prior in-person medical evaluation for internet prescribing unless an applicable exception permits otherwise; the temporary rule is one such pathway. A clinician who has already conducted the required in-person evaluation may be in a different position. ^{20, 13}

🔵 The current one — the fourth extension, published in the Federal Register on December 31, 2025 — runs from January 1, 2026 through December 31, 2026. ¹³

🔵 The official White House Office of Information and Regulatory Affairs review list records DEA's Special Registrations for Telemedicine final rule, RIN 1117-AB40, as received on August 25, 2026 as pending on its September 10 list, checked September 11, 2026. A pending review is not a published final prescribing rule, an effective date, or a guarantee of particular terms. ¹⁵

Now do the calendar maths on a commitment. These examples start on the first day of each month and show approximate time extending beyond the current December 31 endpoint — not a predicted interruption:

📄 Maximus's terms reserve the company's ability to end a program for reasons including medication shortages or regulatory changes. They also say that, if the program is discontinued during a commitment, patients receive a prorated refund for unused services unless prohibited by law. That company-discontinuation clause is different from a patient choosing to leave. Ask how the general terms and later refund policy apply to your actual situation. ^{3, 4}

To be completely fair about this: a change to controlled-substance rules could affect more than Maximus, including our partners. It is not evidence that online TRT is ending. And enclomiphene is not testosterone: do not apply testosterone's controlled-substance deadline to an enclomiphene-only prescription. Clinical and state-law requirements still matter. ^{13, 14, 21, 38}

Our editorial conclusion: this isn't a reason to stop treatment or avoid telehealth. It is a reason to ask any provider — ours included — a simple question: what happens to my appointments, charges, remaining medication, and refunds if a rule changes? A six-month term that begins in September also runs into 2027; it limits commitment length, not regulatory exposure.

Can the provider treat you in your state?

The temporary federal rule does not erase state licensure, prescribing, or pharmacy requirements. For testosterone, the federal pathway has conditions including a legitimate medical purpose and the required type of clinical encounter; it is not an online-questionnaire loophole. Confirm the named clinician's authority where you will physically be, any required in-person visit, the exact treatment offered there, and the dispensing pharmacy before paying. ^{13, 38}

We have not verified an all-state claim for any individual treatment in this comparison. A site's state selector or nationwide marketing is not the same as a completed clinical and pharmacy check.

---

Before you switch: has your low testosterone actually been confirmed?

A diagnosis of testosterone deficiency requires symptoms or signs plus consistently low testosterone confirmed with repeat early-morning testing — not one result, and not a symptom quiz. If you've only ever had a single test, that's the gap to close before you pay another subscription. ^{17, 29}

🔵 The Endocrine Society's July 16, 2026 statement calls for a clinician's diagnosis based on symptoms and consistently low, accurately measured testosterone, including at least two early-morning, fasting tests. Its clinical guideline also addresses when free testosterone is needed and stresses looking for the cause. A provider's commercial screening panel is not proof that the full diagnostic process has been completed. ^{29, 17}

Thresholds vary between guidelines and laboratory assays. A level near 300 ng/dL is a common clinical reference point, not a universal diagnosis by itself. ^{29, 17}

A quick definition, because it matters: total testosterone is all the testosterone in your blood, both bound to proteins and free. Free testosterone is the fraction not bound. The measurements answer different questions; a clinician decides whether both are needed. ¹⁷

About that "1 in 4" statistic

You'll see versions of this statistic in hormone-care marketing, so it's worth tracing once.

📄 Maximus's testosterone page headlines “1 in 4 men over 30 has sub-optimal testosterone,” with a citation to Araujo and colleagues in the Journal of Clinical Endocrinology & Metabolism, 2007. The original study's abstract describes a sample of 1,475 men aged 30–79 in the Boston area, not a current national treatment-eligibility estimate. ^{2, 18}

The number is real and it's in there. Approximately 24% of the men studied had total testosterone below 300 ng/dL. That percentage counts a blood-level finding without requiring the study's symptom criteria. ¹⁸

But the paper's own headline finding is different. Symptomatic androgen deficiency was 5.6% under the study's definition, which combined specified low total and free testosterone values with symptoms. Among men over 50 with low testosterone, nearly half had no symptoms. The study did not establish who was an appropriate candidate for treatment. ¹⁸

Why this matters to you and not just to a statistician: the 24% and 5.6% figures answer different research questions. Neither is a substitute for a clinician confirming your diagnosis with the appropriate repeat testing. The useful question before paying isn't which statistic you belong to; it's whether the reason for your symptoms and low results has been properly evaluated. ^{18, 17}

What the FDA changed in 2025 — and requested in 2026

🔵 In February 2025, the FDA made class-wide labeling changes to testosterone products. After the TRAVERSE cardiovascular safety trial, it recommended removing boxed-warning language about increased risk of adverse cardiovascular outcomes. After ambulatory blood pressure monitoring studies, it required a new warning about increased blood pressure across the class. ¹⁶

🔵 That February 2025 action retained the age-related limitation-of-use language at the time. But on June 18, 2026, HHS announced that FDA was requesting its removal, along with changes to prostate-related labeling. Those were requested label revisions; this page does not assume every product label has already changed. ^{16, 31}

FDA's current information page still describes approved testosterone products as treatment for low testosterone associated with a medical condition. A requested label change does not approve compounded preparations, make fatigue alone a diagnosis, or remove the need to check the exact product's current prescribing information. ^{30, 19, 29}

If your reason for treatment is “I'm 45 and tired,” that still needs a clinician who can look at the whole picture. Age or symptoms alone do not settle the diagnosis. ²⁹

When to see someone in person instead of switching clinics

Arrange a focused clinical evaluation rather than just another subscription if you have very abnormal lab results, elevated hematocrit (the percentage of your blood made up of red cells), a prostate or breast cancer history, untreated severe sleep apnea, a recent major cardiovascular event, suspected pituitary or testicular disease, or infertility. These findings need individualized assessment; this list is not a ruling on your eligibility. ^{17, 32}

Primary care, urology, endocrinology, or reproductive urology — depending on what's going on. That's not a brush-off. It's a route to a clinical answer rather than another price quote.

Map your situation to the right care route with Find My TRT Path →

Educational and non-diagnostic. It won't diagnose low testosterone, determine eligibility, pick a medication, or guarantee a prescription.

---

What changes if fertility is part of this?

🔵 Testosterone taken from outside the body can suppress sperm production. Fertility plans belong in the clinical discussion before selecting a provider or treatment, not after. A different subscription or an added medicine cannot guarantee preserved or restored fertility. ³²

Enclomiphene is often marketed as the fertility-friendly option because it works through your own hormonal signal rather than replacing it. The evidence is narrower than the advertising, and no provider can promise you preserved or restored fertility on any timeline. Neither can we. ^{32, 34}

📄 Maximus publishes fertility-marker results from its own open-label observational studies. Those are company-run findings, not proof that an independent team reproduced the same outcomes or that fertility is assured for an individual patient. We're describing the limitation, not dismissing the data. ²

If you and your partner are trying to conceive in the next year or two, start with a reproductive urologist or another fertility-aware clinician — a semen analysis and a couple-level evaluation matter more than which subscription is convenient. We go through the pooled trial evidence in detail on our enclomiphene provider comparison and in TRT and fertility. ³²

For tested athletes and service members: clomifene is on the World Anti-Doping Agency's Prohibited List, and the Department of Defense's Operation Supplement Safety also flags enclomiphene. A civilian prescription does not, by itself, settle sports or military rules. Ask your anti-doping authority or military healthcare provider before assuming it does. ^{22, 21}

---

How do you arrange a switch without an avoidable care gap?

Request your records and a clinician-led handoff before relying on a new refill. Recent labs may be usable, but the new prescriber decides whether they are sufficient; transferring records is not a prescription guarantee. Ask both providers about timing rather than assuming intake and pharmacy fulfillment will take one or two weeks. ^{23, 26, 13}

Work through these in order:

1. Download everything first. Lab reports, medication list, visit notes. Do this before you cancel, not after. If the portal does not supply them, request records from the treating practice. For HIPAA-covered providers, the right to access records is not generally lost because you cancel or owe a bill.
2. Screenshot your current plan page — term length, monthly rate, renewal date. If pricing changes later, you'll want the record.
3. Check whether your labs are recent enough to reuse. 📄 Maximus's materials say qualifying results from the last six months can work for its intake; other providers set their own requirements. Ask before paying for a panel you may not need. An accepted outside lab doesn't automatically complete a new clinician's evaluation.
4. Ask about the new intake and refill timeline before committing. Get the clinician's continuity plan while you still have time to arrange it. Paying for a new intake is not a guarantee of acceptance or an immediate refill.
5. Ask the new clinician about continuity specifically — dose, format, and what changes. A new prescriber makes a new prescribing decision. Transferring records isn't a guaranteed refill.
6. Turn off auto-renewal at Maximus when you have decided not to renew. It won't shorten a committed term, but it stops the next one starting under the published process. If a clinician-documented health reason applies, ask support in writing about the medical-exit clause and the remaining balance.
7. Confirm the named treating clinician is authorised where you'll physically be and ask whether an in-person visit is required before paying for the new plan.
8. Get the renewal rate, the renewal date, and the dose-change policy in writing. ^{37, 23, 3, 4, 38}

The nine questions worth getting in writing before you pay anyone

1. What's my total charge in month one, including labs, medication, shipping, and any membership?
2. What are all the charge dates and amounts over the next twelve months?
3. When is the next renewal, and at what rate?
4. What am I committed to, and what happens if I cancel in month three?
5. If my prescription changes mid-term, what happens to my monthly charge?
6. Are repeat labs included or billed separately — how much, and how often?
7. Is the exact product I'll receive FDA-approved or compounded, and which pharmacy dispenses it?
8. Who is my prescribing clinician, and are they authorised in my state?
9. What are the exact steps and deadlines to cancel, and which charges can't be refunded?

A clinic that answers all nine clearly, in writing, before you pay has told you something useful about how it operates. A clinic that won't is also telling you something.

If you've got answers you're happy with:

See Male Excel's published program costs → · See Taurus Meds' enclomiphene offer → · Still deciding? Use Find My TRT Path →

---

What did we actually verify?

What we actually verified — September 11, 2026. We read the public documents linked below and recalculated the quoted amounts. This is a comparison of published offers, not a patient trial or a verification of an individual's care.

What we read firsthand: Maximus's testosterone pages, eighteen-protocol price matrix, laboratory policy, subscription-change instructions, Terms of Use, and Return, Refund & Subscription Policy. Male Excel's pricing page, oral-product page, and terms. Taurus Meds' enclomiphene offer, terms, and refund policy. Hone's current Plus offer, FAQ, lab schedules, and older payment-breakdown PDF. We also checked Defy's public site and Marek's diagnostics-to-care links.

Medical and public-record checks: the Federal Register extension, HHS's explanation, DEA's scheduling page, and OIRA's pending-review record; FDA and HHS labeling communications; the Endocrine Society guideline and July 2026 statement; AUA/ASRM male-infertility guidance; the Clomid label and FDA enclomiphene materials; and the published abstract of Araujo's 2007 study. We used the insurer, IRS, and HHS sources for coverage examples, medical-expense accounts, records, and state-licensing principles.

^{1, 3, 4, 7, 8, 10, 24, 26, 11, 27, 17, 32, 13, 38}

What we could not confirm, and won't guess at:

• Whether Taurus's recurring $17.99 fee applies to the selected hormone-care purchase, is already included, or is billed monthly.
• Which SERM and added ingredients are actually in today's Triclozene order, and which of Male Excel's two oral prices applies.
• Treatment-specific availability, an assigned clinician's authority, or an individual pharmacy assignment for any reader.
• Complete current treatment quotes for Defy Medical and Marek Health.
• Whether Maximus's home kit supplies every marker needed in an individual plan; its public descriptions conflict.
• Whether each clinic includes the required repeat early-morning diagnostic tests, rather than only a screening kit or later monitoring panels.
• A complete first-year cash total where testing, renewal, fees, or whole refill blocks remain unresolved.

What we did not do: we did not enrol as patients, take any medication, test any checkout or cancellation flow, time anyone's customer support, verify individual clinician or pharmacy licences, or establish product-specific coverage in any state. These are published offers, not personal quotes.

Why there are no star ratings or testimonials on this page: this research did not include an attributable customer-experience sample suitable for comparing billing or care. We have not filled that gap with anonymous summaries, invented quotations, or treatment-success stories. Customer reports can inform service questions; they cannot establish medical safety or a typical treatment result.

Read more about how we work: How We Review TRT Providers and our editorial standards.

---

What else should you know before choosing a Maximus alternative?

Changing the company, changing the medicine, and changing how you pay are separate decisions. These answers cover the final checks before accepting a new agreement.

Frequently asked questions

Can I cancel Maximus at any time? You can turn off auto-renewal through the published dashboard process. A month-to-month plan then runs to the end of its paid period; a committed plan keeps its agreed term. The general terms describe a health-related exit, while the later refund policy is more restrictive, so get a written answer about your agreement rather than assuming the remaining balance disappears. ^{3, 4}

Will Maximus refund me if I stop early? Its published subscription policy generally says no refund for the unused part of a patient-cancelled committed term, and consultation and lab charges are nonrefundable under that policy. But its general terms also address medical cancellation and a prorated refund if the company discontinues a program. Ask which rule applies, whether shipments continue, and exactly what remains payable or refundable. ^{3, 4}

What's the cheapest alternative to Maximus? There isn't one verified cheapest route for everyone. Compare the same treatment and all required charges, including anything still owed to Maximus. Its six-month base rate matches its twelve-month rate, so a shorter new term may solve the commitment issue without changing providers; an insurance-based route also deserves a written quote. ^{1, 3, 35}

Which online TRT providers have no contract? Male Excel states "No Contract, Cancel Anytime" on every pricing tier. Hone Health allows cancellation at any time, effective at the end of the billing period. Taurus allows cancellation effective at the end of the current paid term. Maximus offers a month-to-month plan and a one-time purchase option alongside its committed tiers. ^{7, 12, 10, 1}

Can I get enclomiphene somewhere other than Maximus? Yes. Taurus Meds, Hone Health, and several other providers list enclomiphene. Confirm which molecule you're being prescribed, because clomiphene and enclomiphene are not the same drug. Our enclomiphene provider comparison goes through seven offers by ingredient. ^{24, 26, 33}

Do I need new bloodwork to switch? Possibly. Maximus says qualifying outside results from the last six months may be accepted for its own intake; that is not another provider's acceptance rule. Ask the new clinician about markers, timing, repeat morning testing, and the fee before paying for another panel. ^{23, 17}

What happens to my testosterone if I stop? That depends on which protocol you were on and why you're stopping, and it's a question for the clinician who prescribed it. Ask for a clinical plan before changing treatment; this page cannot tell you how to stop, restart, or change a dose.

Is Maximus legitimate? Maximus has a current public treatment site and publishes pricing, clinical-process information, terms, and compounding disclosures. That does not independently verify the clinician or pharmacy assigned to you. Check those names and their authority for your location; this review did not establish an issuer-verified certification or complete a license check for your care. ^{2, 3, 38}

Does insurance cover online TRT? It can, depending on the clinician, network, diagnosis, exact medication, and plan rules. A cash-pay clinic is not made insurance-covered just because the visit is online, and normal results during ongoing treatment do not by themselves prove coverage must end. Check visits, tests, and drugs separately; ask your administrator about any FSA/HSA use. ^{35, 36}

Is online TRT still going to be legal next year? The verified temporary federal pathway for qualifying controlled-medication prescribing without a prior in-person exam ends December 31, 2026. A separate final rule was pending OIRA review on September 11, but no outcome is assumed here. That is not a January 1 ban: prior in-person care, applicable exceptions, any later federal action, and state rules affect the answer. ^{13, 14, 15, 38}

Is enclomiphene safer than testosterone? That's not an established general claim. Enclomiphene is not FDA-approved, and the trials considered in FDA's review do not establish comparative long-term safety for an individual patient. A different legal classification is not a safety rating. ^{21, 34}

Can a provider guarantee I'll be approved? No, and be careful with anything that implies otherwise. A clinical evaluation is required, and a payment, questionnaire, or lab kit does not guarantee a prescription. Read the refund terms before you submit a card. ^{26, 13}

---

Still not sure which TRT care route fits you?

Use our free Find My TRT Path tool. It helps you explore a care route and the questions to ask before you pay anyone; it does not replace an evaluation or decide which medicine is right for you.

It's educational and non-diagnostic. It does not diagnose low testosterone, determine your medical eligibility, select a medication, or guarantee a prescription.

Find My TRT Path →

Read our privacy policy before sharing information, and keep copies of your medical records with your treating practice.

---

Related reading

• Best Enclomiphene Providers: 7 Compared
• What TRT actually costs
• TRT treatment options compared
• Online vs. local TRT care
• TRT and fertility
• How We Review TRT Providers

---

Last verified September 2026. We checked the public sources on September 11, 2026. Prices, plan terms, and rules can change; the document conflicts and untested items above remain explicit. Get an updated written quote before paying. If something here is out of date, send a correction.

Affiliate disclosure: Male Excel and Taurus Meds are commercial partners of TRT Provider Guide. Provider links on this page point to public information, not tracked referral or enrollment links. Commercial relationships do not determine what we publish, who we include, or what we conclude.

Educational information, not medical advice. This page has not been medically reviewed. It cannot diagnose low testosterone or tell you whether any treatment is right for you. Talk to a licensed clinician. If you have chest pain, severe shortness of breath, or another urgent symptom, seek emergency care.

---

Sources

Checked September 11, 2026. Provider sources establish what a company publishes, not independent confirmation of the care any individual receives.

1. Maximus — Enclomiphene Subscription Plans & Pricing; eighteen-protocol matrix

2. Maximus — Testosterone protocols, promotional offer, and site-wide study and compounding disclosures

3. Maximus — Terms of Use; subscription commitments, medical cancellation, program discontinuation, and appointment fees

4. Maximus — Return, Refund & Subscription Policy; effective April 15, 2026

5. Maximus — How to Switch or Modify Your Testosterone Subscription

6. Maximus — How to Get Enclomiphene Online

7. Male Excel — Hormone treatment costs, membership, treatment examples, and conflicting oral prices

8. Male Excel — Triclozene oral-product description

9. Male Excel — Terms and Conditions; cash-pay service and refund restrictions

10. Taurus Meds — Terms of Service; membership fee, cancellation, and partner disclosures

11. Hone Health — Older HRT membership payment-breakdown PDF, dated May 28, 2026; $129 monthly / $1,548 annual figures

12. Hone Health — Membership Frequently Asked Questions

13. Federal Register — Fourth Temporary Extension of Telemedicine Flexibilities for Prescription of Controlled Medications

14. HHS — DEA and HHS extend telemedicine prescribing flexibilities through 2026

15. Office of Information and Regulatory Affairs — Executive Order review list; DEA Special Registrations for Telemedicine, RIN 1117-AB40, pending as checked September 11, 2026

16. FDA — Class-wide labeling changes for testosterone products, February 28, 2025

17. Endocrine Society — Testosterone Therapy for Hypogonadism clinical practice guideline

18. Araujo AB and colleagues — Prevalence of symptomatic androgen deficiency in men; published abstract, J Clin Endocrinol Metab. 2007;92:4241–4247

19. FDA — Compounding and the FDA: Questions and Answers

20. DEA — Drug Scheduling; testosterone listed in Schedule III

21. Operation Supplement Safety — Clomiphene and Enclomiphene: Drugs, Not Dietary Supplements; updated January 12, 2026

22. World Anti-Doping Agency — The Prohibited List

23. Maximus — Lab Testing Costs and Policies

24. Taurus Meds — Enclomiphene product offer, initial testing, and marketing claims

25. Taurus Meds — Refund Policy; cancellation lead time and scope

26. Hone Health — Current Plus Membership for Men; membership, medicine, and initial-test figures

27. Hone Health — TRT patient laboratory schedule

28. Hone Health — Clomiphene and non-TRT laboratory schedule

29. Endocrine Society — Statement on Testosterone Replacement Therapy, July 16, 2026

30. FDA — Testosterone Information; current approval scope and labeling updates

31. HHS — Requested Updates to Testosterone Therapy Product Labels, June 18, 2026

32. AUA/ASRM — Diagnosis and Treatment of Infertility in Men, Part II

33. DailyMed — Clomid prescribing information; indication and clomiphene isomers

34. FDA — Enclomiphene citrate review materials for the Pharmacy Compounding Advisory Committee, June 2022

35. Aetna — Testosterone Cypionate Injections; medical-necessity and continuation criteria

36. IRS — Publication 969: Health Savings Accounts and Other Tax-Favored Health Plans

37. HHS — Your Medical Records; access rights at HIPAA-covered providers

38. HHS Telehealth — Licensing Across State Lines

39. Defy Medical — Public care and service information

40. Marek Diagnostics — Public diagnostics and Guided Optimization care links

41. Maximus — Enclomiphene product information

42. Maximus — Oral testosterone; custom-compounded formulation disclosure

43. Organon — Pregnyl (chorionic gonadotropin) U.S. prescribing information; labeled indications